Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients (vol 51, pg 594, 2018)

被引：1
|
作者：
Dhaese, Sofie A. M. [1 ]
Roberts, Jason A. [2 ,3 ,4 ]
Carlier, Mieke [5 ]
Verstraete, Alain G. [5 ,6 ]
Stove, Veronique [5 ,6 ]
De Waele, Jan J. [1 ]
机构：
[1] Ghent Univ Hosp, Intens Care, C Heymanslaan 10, B-9000 Ghent, Belgium
[2] Univ Queensland, Fac Med, Brisbane, Qld, Australia
[3] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia
[4] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[5] Ghent Univ Hosp, Lab Med, Ghent, Belgium
[6] Univ Ghent, Clin Chem Microbiol & Immunol, Ghent, Belgium
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2019年 / 54卷 / 03期
关键词：
D O I：
10.1016/j.ijantimicag.2019.07.022
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：380 / 380
页数：1
相关论文
共 50 条
  • [41] Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
    Selig, Daniel J.
    Akers, Kevin S.
    Chung, Kevin K.
    Kress, Adrian T.
    Livezey, Jeffrey R.
    Por, Elaine D.
    Pruskowski, Kaitlin A.
    DeLuca, Jesse P.
    ANTIBIOTICS-BASEL, 2022, 11 (05):
  • [42] Pharmacokinetics of Piperacillin in Critically Ill Australian Indigenous Patients with Severe Sepsis
    Tsai, Danny
    Stewart, Penelope
    Goud, Rajendra
    Gourley, Stephen
    Hewagama, Saliya
    Krishnaswamy, Sushena
    Wallis, Steven C.
    Lipman, Jeffrey
    Roberts, Jason A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (12) : 7402 - 7406
  • [43] Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis
    Selig, Daniel J.
    DeLuca, Jesse P.
    Chung, Kevin K.
    Pruskowski, Kaitlin A.
    Livezey, Jeffrey R.
    Nadeau, Robert J.
    Por, Elaine D.
    Akers, Kevin S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (08) : 1091 - 1102
  • [44] First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
    Roberts, Jason A.
    Kirkpatrick, Carl M. J.
    Roberts, Michael S.
    Dalley, Andrew J.
    Lipman, Jeffrey
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (02) : 156 - 163
  • [45] Daptomcycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis (vol 39, pg 19, 2011)
    Vilay, A. M.
    Grio, M.
    Depestel, D. D.
    CRITICAL CARE MEDICINE, 2011, 39 (05) : 1247 - 1247
  • [46] Population Pharmacokinetics of Ganciclovir in Critically Ill Patients
    Krens, Stefanie D.
    Hodiamont, Caspar J.
    Juffermans, Nicole P.
    Mathot, Ron A. A.
    van Hest, Reinier M.
    THERAPEUTIC DRUG MONITORING, 2020, 42 (02) : 295 - 301
  • [47] Population pharmacokinetics of daptomycin in critically ill patients
    Soraluce, A.
    Asin-Prieto, E.
    Rodriguez-Gascon, A.
    Barrasa, H.
    Maynar, J.
    Carcelero, E.
    Soy, D.
    Isla, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (02) : 158 - 165
  • [48] Population Pharmacokinetics of Fosfomycin in Critically Ill Patients
    Parker, Suzanne L.
    Frantzeskaki, Frantzeska
    Wallis, Steven C.
    Diakaki, Chryssa
    Giamarellou, Helen
    Koulenti, Despoina
    Karaiskos, Ilias
    Lipman, Jeffrey
    Dimopoulos, George
    Roberts, Jason A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (10) : 6471 - 6476
  • [49] Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
    Pyry Antti Välitalo
    Tuula Ahtola-Sätilä
    Andrew Wighton
    Toni Sarapohja
    Pasi Pohjanjousi
    Chris Garratt
    Clinical Drug Investigation, 2013, 33 : 579 - 587
  • [50] Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
    Valitalo, Pyry Antti
    Ahtola-Satila, Tuula
    Wighton, Andrew
    Sarapohja, Toni
    Pohjanjousi, Pasi
    Garratt, Chris
    CLINICAL DRUG INVESTIGATION, 2013, 33 (08) : 579 - 587
12345